Jane Street’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.8M | Buy |
1,221,750
+688,881
| +129% | +$7.76M | ﹤0.01% | 682 |
|
|
2025
Q1 | $5.38M | Buy |
532,869
+502,311
| +1,644% | +$5.07M | ﹤0.01% | 1312 |
|
|
2024
Q4 | $362K | Buy |
30,558
+15,962
| +109% | +$189K | ﹤0.01% | 4399 |
|
|
2024
Q3 | $168K | Sell |
14,596
-2,493,187
| -99% | -$28.8M | ﹤0.01% | 5310 |
|
|
2024
Q2 | $26.5M | Buy |
2,507,783
+1,806,506
| +258% | +$19.1M | 0.01% | 513 |
|
|
2024
Q1 | $7.39M | Buy |
701,277
+386,429
| +123% | +$4.07M | ﹤0.01% | 1002 |
|
|
2023
Q4 | $3.54M | Sell |
314,848
-1,494,423
| -83% | -$16.8M | ﹤0.01% | 1837 |
|
|
2023
Q3 | $21.1M | Buy |
1,809,271
+1,523,117
| +532% | +$17.8M | 0.01% | 410 |
|
|
2023
Q2 | $2.88M | Buy |
286,154
+41,895
| +17% | +$422K | ﹤0.01% | 2018 |
|
|
2023
Q1 | $1.8M | Buy |
244,259
+155,681
| +176% | +$1.15M | ﹤0.01% | 2165 |
|
|
2022
Q4 | $708K | Buy |
88,578
+73,660
| +494% | +$589K | ﹤0.01% | 3023 |
|
|
2022
Q3 | $48K | Buy |
+14,918
| New | +$48K | ﹤0.01% | 5109 |
|
|
2022
Q2 | – | Sell |
-49,897
| Closed | -$246K | – | 6171 |
|
|
2022
Q1 | $246K | Buy |
+49,897
| New | +$246K | ﹤0.01% | 4505 |
|